Helicobacter pylori and Microcirculation

被引:9
|
作者
Suzuki, Hidekazu [1 ]
Suzuki, Masayuki
Imaeda, Hiroyuki [2 ]
Hibi, Toshifumi
机构
[1] Keio Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Shinjuku Ku, Tokyo 1608585, Japan
[2] Keio Univ Hosp, Ctr Diagnost & Therapeut Endoscopy, Shinjuku Ku, Tokyo, Japan
基金
日本学术振兴会;
关键词
microcirculation; H; pylori; gastric mucosa; endothelial cell; platelet; leukocyte; cytokine; GASTRIC-MUCOSAL MICROCIRCULATION; CENTRAL SEROUS CHORIORETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; UREASE IMMUNOGLOBULIN-Y; ALPHA-METHYL HISTAMINE; CORONARY HEART-DISEASE; MONGOLIAN-GERBILS; IN-VIVO; CONGESTIVE GASTROPATHY; LEUKOCYTE ACTIVATION;
D O I
10.1080/10739680902949953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microcirculation is one of the susceptible targets in the pathogenesis of disorders caused by exogenous pathogens, such as the well-known bacterium, Helicobacter pylori (Hp). While extensive studies have been published on the kinetics of Hp infection, only a few have dealt with the microcirculatory aspects of Hp-induced disorders. This review summarizes the recent developments in the elucidation of the pathophysiology of disorders. This review summarizes the recent developments in the elucidation of the pathophysiology of disorders caused by Hp infection, focusing on the microcirculatory aspect. Animal and human studies were systematically reviewed to identify published data on the microcirculatory aspects of Hp infection. This updated summary of the microcirculatory aspects of Hp-induced disorders illustrates potential approaches that might be used to clarify the pathophysiology of the gastric and extragastric sequelae of Hp infection and the therapeutic strategies that could be adopted. Microcirculation (2009) 16, 547-558. doi:10.1080/10739680902949953
引用
收藏
页码:547 / 558
页数:12
相关论文
共 50 条
  • [1] Of blood and guts:: Association between Helicobacter pylori and the gastric microcirculation
    Kalia, N
    Bardhan, KD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (09) : 1010 - 1017
  • [2] Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo
    Kalia, N
    Bardhan, KD
    Reed, MWR
    Jacob, S
    Brown, NJ
    DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (07) : 1343 - 1351
  • [3] Helicobacter pylori and cardiovascular disease
    Kucukazman, M.
    Yeniova, O.
    Dal, K.
    Yavuz, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (19) : 3731 - 3741
  • [4] Helicobacter pylori and extragastric diseases
    Goni, Elisabetta
    Franceschi, Francesco
    HELICOBACTER, 2016, 21 : 45 - 48
  • [5] Therapy of Helicobacter pylori
    McLoughlin, R
    Racz, I
    Buckley, M
    O'Connor, HJ
    O'Morain, C
    HELICOBACTER, 2004, 9 : 42 - 48
  • [6] Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction
    Fraser, AG
    Scragg, RK
    Cox, B
    Jackson, RT
    INTERNAL MEDICINE JOURNAL, 2003, 33 (07) : 267 - 272
  • [7] Effects of Chronic Administration of Helicobacter pylori Extracts on Rat Gastric Mucosal Microcirculation In Vivo
    N. Kalia
    K.D. Bardhan
    M.W.R. Reed
    S. Jacob
    N.J. Brown
    Digestive Diseases and Sciences, 2000, 45 : 1343 - 1351
  • [8] Utilization Rate of Helicobacter pylori Immunohistochemistry Is Not Associated With the Diagnostic Rate of Helicobacter pylori Infection
    Son, Jung H.
    Lebwohl, Benjamin
    Sepulveda, Antonia R.
    Lagana, Stephen M.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (09) : 694 - 698
  • [9] Complementation System for Helicobacter pylori
    Kim, Jinmoon
    Kim, Sung-Whan
    Jang, Sungil
    Merrell, D. Scott
    Cha, Jeong-Heon
    JOURNAL OF MICROBIOLOGY, 2011, 49 (03) : 481 - 486
  • [10] The influence of mucus microstructure and rheology in Helicobacter pylori infection
    Bansil, Rama
    Celli, Jonathan P.
    Hardcastle, Joseph M.
    Turner, Bradley S.
    FRONTIERS IN IMMUNOLOGY, 2013, 4